CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 21,817	$ 27,606	$ 67,962	$ 73,418
General and administrative	6,696	7,710	21,912	24,494
Total operating expenses	28,513	35,316	89,874	97,912
Loss from operations	(28,513)	(35,316)	(89,874)	(97,912)
Other income:
Interest income	954	2,126	3,672	6,310
Total other income	954	2,126	3,672	6,310
Net loss	$ (27,559)	$ (33,190)	$ (86,202)	$ (91,602)
Net loss per share attributable to common stockholders, basic	$ (0.4)	$ (0.49)	$ (1.26)	$ (1.37)
Net loss per share attributable to common stockholders, diluted	$ (0.4)	$ (0.49)	$ (1.26)	$ (1.37)
Weighted-average common shares outstanding, basic	68,465,801	67,607,713	68,266,044	66,973,771
Weighted-average common shares outstanding, diluted	68,465,801	67,607,713	68,266,044	66,973,771
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale marketable securities	$ 138	$ 156	$ 145	$ 490
Total other comprehensive income (loss)	138	156	145	490
Comprehensive loss	$ (27,421)	$ (33,034)	$ (86,057)	$ (91,112)